Hypnotic Efficacy of Triazolam and Methyprylon in Insomniac In-Patients

@article{Lomen1976HypnoticEO,
  title={Hypnotic Efficacy of Triazolam and Methyprylon in Insomniac In-Patients},
  author={Pavel L. Lomen and Otto I. Linet},
  journal={Journal of International Medical Research},
  year={1976},
  volume={4},
  pages={55 - 58}
}
  • P. Lomen, O. Linet
  • Published 1 January 1976
  • Medicine, Psychology
  • Journal of International Medical Research
The hypnotic effect of a new triazolobenzodiazepine, triazolam (Halcion ®) 0.5 mg and methyprylon 300 mg was compared in twenty oncologic inpatient volunteers with insomnia using the preference technique. On the first night of the two-night trial, triazolam or methyprylon was given on a double-blind basis and on the second night the patients received the alternate medication. Following each trial night the patients were interviewed in regard to their sleep. Of the seventeen patients who… 
7 Citations

Tables from this paper

Pharmacology and Hypnotic Efficacy of Triazolam
TLDR
Overall, triazolam is an effective and safe compound for the symptomatic treatment of insomnia complaints, making it the shortest acting benzodiazepine available in the United States.
Triazolam: A Review of its Pharmacological Properties and Therapeutic Efficacy in Patients with Insomnia
TLDR
In human sleep laboratory studies, triazolam, like other benzodiazepine hypnotics, caused dose-dependent effects on sleep stages in both healthy volunteers and insomniac patients, reducing stage ‘wake’ and stage 1 sleep, increasing stage 2 and usually having minimal effects on stages 3 and 4.
WITHDRAWN: Benzodiazepines and related drugs for insomnia in palliative care.
  • A. Hirst, R. Sloan
  • Medicine, Psychology
    The Cochrane database of systematic reviews
  • 2013
TLDR
The effectiveness and safety of benzodiazepine receptor agonists such as Zolpidem, Zopiclone and Zaleplon for insomnia in palliative care and their utility in patients with progressive incurable conditions is assessed.
Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
  • R. Rosenberg
  • Psychology, Medicine
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
  • 2006
TLDR
New agents that offer relief of sleep maintenance insomnia without residual next day impairment while improving next day function are needed.
Commentary 1
2. Pakes GE, Brogden RN, Heel RC et al. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs 1981 ;22:81-110. 3. Eberts FS, Philopoulos Y,
Mechanism of action of aromatic amines that short-circuit the visual cycle.
TLDR
The "short-circuit" hypothesis is investigated more fully and Numerous phenetidine-like molecules are assayed for their ability to inhibit rhodopsin formation and 11-cis-retinyl palmitate formation in the living frog eye.

References

SHOWING 1-10 OF 17 REFERENCES
Comparison of triazolam and methyprylon as a hypnotic in insomniacs.
TLDR
Analysis of the various sleep parameters showed that triazolam helped the patients sleep more than methyprylon, and there were fewer awakenings on trizolam, a longer duration of sleep, and a better feeling in the a.m.
The Hypnotic Efficacy of Triazolam
TLDR
As a hypnotic medication, triazolam was found to be thirty to sixty times as potent as flurazepam, on a weight basis, and demonstrated significant activity in prolonging the duration and increasing the depth of sleep, and in reducing the number of times of waking.
Triazolam in insomniac family practice patients
TLDR
Findings suggest that type and degree of emotional symptomatology may affect the response of insomniac patients to hypnotics, and triazolam emerged as an especially effective hypnotic for initially more depressed insomNIac patients.
A comparative study of three hypnotics: methyprylon, glutethimide and chloral hydrate.
  • W. T. Brown
  • Psychology, Medicine
    Canadian Medical Association journal
  • 1970
TLDR
Methyprylon was found statistically to be the fastest sleep-inducing agent, whereas glutethimide (Doriden) proved to beThe slowest of the three hypnotics with respect to sleep induction time.
Comparative Efficacy of Hypnotics
  • E. Hare
  • Psychology, Medicine
    British journal of preventive & social medicine
  • 1955
TLDR
A satisfactory means of comparing the clinical efficacy of hypnotics would have two valuable uses: it would enable new hypnotics to be tested against long-established drugs, and it would permit a comparison of the efficacy of those already in common use.
COMPARATIVE EFFICACY OF HYPNOTICS A ' SELF-CONTROLLED , SELF-RECORDED CLINICAL TRIAL IN NEUROTIC PATIENTS
TLDR
A satisfactory means of comparing the clinical efficacy of hypnotics would have two valuable uses: it would enable new hypnotics to be tested against long-established drugs, and it would permit a comparison of the efficacy of those already in common use.
Hypnotics and altered sleep-dream patterns. I. All-night EEG studies of glutethimide, methyprylon, and pentobarbital.
TLDR
A comparative analysis of studies relating the administration and withdrawal of three hypnotics in varying dosages to effects uponallsleep stages is presented.
Controlled Comparison of Four Sedative Drugs in Elderly Patients
TLDR
The results show that in a dosage of 100 mg.
Sleep Physiology and Pathology: A Symposium.
TLDR
A symposium on the physiology and pathology of sleep intended primarily for practicing physicians was held May 1968 at the Brain Research Institute of the University of California at Los Angeles and the proceedings have now been made available in a particularly attractive hard-cover volume.
...
1
2
...